Is telmisartan effective in treating non-alcoholic steatohepatitis?
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are well-recognized causes of progressive liver disease leading to cirrhosis and hepatocellular carcinoma. To date, no therapy provided evidence of significant efficacy in these conditions and no approved therapeuti...
Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke
HAMILTON August 31, 2008 -- An international study led by Canadian researchers has found that telmisartan, a medication used to lower blood pressure, reduced the outcome of cardiovascular death, heart attack or stroke in people who are unable to tolerate a widely available and effective standard ...
Newer Blood Pressure Drug Better for Some Heart Patients, Diabetics
... Study found telmisartan
offered slight benefit for those unable to take AC...t the angiogenesis-receptor blocker (ARB) known as telmisartan
worked well for the 20 percent of patients with va...vascular disease or high-risk diabetes took either telmisartan
or a placebo, and were followed for almost five ye...
Newer Blood Pressure Drug No Better Than Placebo in Preventing Stroke
... Patients may need to be on telmisartan
longer to see positive effect, researchers say
...ug. 27 (HealthDay News) -- The blood pressure drug telmisartan
does not lower the rate of stroke, cardiovascular ...ients who have had a stroke, a new study finds.
is an angiotensin II receptor blocker, which works...
ACE Inhibitor as Effective as More Expensive Blood Pressure Drug
...ith the widely used ACE inhibitor ramipril (Altace) and those given the ARB telmisartan
"This is the first study in such a population that shows ACE...wo groups -- 16.5 percent for those taking ramipril and 16.7 percent in the telmisartan
group. It was also about the same in a group prescribed both medications, 1...
Telmisartan in Medical Technology
New Study Shows That telmisartan has Greater Renoprotective
Potential Thanlosartan in Hypertensive Patients With Type 2
MILAN, Italy, June 15 /CNW/ - Today AMADEO, one of the
first studies to compare the protective potential of two
angiotensin receptor blockers in hypertensive patients with
diabetic nephropathy, was presented at the European Society
of Hypertension, Milan. The results from this study show that ...
TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet
"Previously, the ONTARGET trial showed that telmisartan
effective as the ACE inhibitor ramipril in ...r hospitalizations were
significantly reduced with telmisartan
(894 vs. 980; p=0.025). Therapy with
discontinuation (640 patients discontinued taking telmisartan
taking placebo, p=0.051). The most frequen...
PRoFESS(R) Results Announced at XVII European Stroke Conference
...t between academia and the sponsor,
Boehringer Ingelheim. Co-funders of the telmisartan
arm of the study in
selected countries are Bayer Schering Pharma and GlaxoS...please
visit http://www.aggrenox.com .
About Micardis(R) (telmisartan)
is marketed in the United States by Boehringer Ingelheim as
Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population
... Results of ONTARGET (ONgoing telmisartan
Alone and in combination with
Ramipril Global End...) was 1.01, with a 95 percent CI of 0.94 -
is now the only ARB to have demonstrated cardio an...was prevented.(2)
"The ONTARGET trial shows that telmisartan
is a well-tolerated
treatment in high-risk cardiov...
New Data Presented on Micardis (Telmisartan) Tablets in
Hypertensive Patients With Type 2 Diabetes
...d-titration, multicenter, parallel group, 1-year treatment
trial to compare telmisartan
40 mg titrated to 80 mg versus
losArtan 50 mg titrated to 100 mg, in hypert...ger-ingelheim.com .
(1) Burgess E et al. Efficacy of telmisartan
compared with losartan in
reducing proteinuria in hypertensive typ...
Telmisartan in Biological News
Blood pressure drug telmisartan shows powerful activity against stroke
NEW YORK (Dec. 12, 2007) -- Telmisartan, a drug widely used to help control blood pressure, may have uniquely potent activity in preventing stroke, according to a new study conducted in an animal model.
Whether they used the drug alone or in combination with a different type of antihypertensive...